Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.63%
median of 782 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Satellos Bioscience Inc.
Market Cap
$10.42M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.51M
Gross Margin
N/A
TTM Avg
-101.19%
3Y Avg
-33.23%
5Y Avg
-22.16%
Market Cap
$10.33M
Gross Margin
-16431.82%
TTM Avg
-8215.91%
3Y Avg
-4057.95%
5Y Avg
-2671.97%
Market Cap
$10.65M
Gross Margin
14.12%
TTM Avg
57.06%
3Y Avg
28.53%
5Y Avg
19.02%
Market Cap
$10.06M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.94M
Gross Margin
89.58%
TTM Avg
88.41%
3Y Avg
-34.57%
5Y Avg
-154.89%
Market Cap
$10.96M
Gross Margin
59.22%
TTM Avg
55.56%
3Y Avg
55.56%
5Y Avg
55.56%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Satellos Bioscience Inc. (MSLE) | $10.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A | -101.19% | -33.23% | -22.16% |
| Polyrizon Ltd. (PLRZ)vs › | $10.32M | N/A | 0.00% | 0.00% | 0.00% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.33M | -16431.82% | -8215.91% | -4057.95% | -2671.97% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | 14.12% | 57.06% | 28.53% | 19.02% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lifeward Ltd. (LFWD)vs › | $9.92M | 35.95% | 35.13% | 34.24% | 39.24% |
| Cerenome, Inc. (CNSY)vs › | $10.94M | 89.58% | 88.41% | -34.57% | -154.89% |
| Caring Brands, Inc. (CABR)vs › | $10.96M | 59.22% | 55.56% | 55.56% | 55.56% |
| MetaVia Inc. (MTVA)vs › | $9.88M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
